Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.69 USD | +1.65% | +8.53% | -35.94% |
May. 01 | Journey Medical Corporation Appoints Joseph M. Benesch as Chief Financial Officer | CI |
Mar. 21 | Transcript : Journey Medical Corporation, 2023 Earnings Call, Mar 21, 2024 |
Financials (USD)
Sales 2024 * | 58.01M | Sales 2025 * | 82.04M | Capitalization | 73.7M |
---|---|---|---|---|---|
Net income 2024 * | -15M | Net income 2025 * | -4M | EV / Sales 2024 * | 1.27 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.9 x |
P/E ratio 2024 * |
-4.99
x | P/E ratio 2025 * |
-18.5
x | Employees | 41 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 49.09% |
Latest transcript on Journey Medical Corporation
1 day | +1.65% | ||
1 week | +8.53% | ||
1 month | -15.37% | ||
3 months | -23.44% | ||
6 months | +6.96% | ||
Current year | -35.94% |
Managers | Title | Age | Since |
---|---|---|---|
Claude Maraoui
FOU | Founder | 57 | 14-09-30 |
Joseph Benesch
DFI | Director of Finance/CFO | 57 | 21-10-31 |
Chief Tech/Sci/R&D Officer | - | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 68 | 14-09-30 | |
Neil Herskowitz
BRD | Director/Board Member | 67 | 20-12-31 |
Miranda Toledano
BRD | Director/Board Member | 47 | 21-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 3.69 | +1.65% | 51,784 |
24-05-02 | 3.63 | +3.42% | 47,993 |
24-05-01 | 3.51 | -4.88% | 62,515 |
24-04-30 | 3.69 | +10.81% | 98,295 |
24-04-29 | 3.33 | -2.06% | 141,312 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.94% | 73.7M | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- DERM Stock